Scancell Holdings PLC

OTCPK:SCNLF (UK)  
$ 0.18 0 (0%) 12:09 AM EST
At Loss
Market Cap:
$ 156.36M
Enterprise V:
$ 162.77M
Volume:
-
Avg Vol (2M):
1.21K
Trade In:
Volume:
-
At Loss
Avg Vol (2M):
1.21K

Business Description

Description
Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.
Name Current Vs Industry Vs History
Cash-To-Debt 0.75
Equity-to-Asset -0.15
Debt-to-Equity -5.67
Debt-to-EBITDA -2.81
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 31.7
3-Year EPS without NRI Growth Rate 4.6
3-Year FCF Growth Rate -4.9
Name Current Vs Industry Vs History
9-Day RSI 0.04
14-Day RSI 1.03
6-1 Month Momentum % 53.21
12-1 Month Momentum % 29.22

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.42
Quick Ratio 3.42
Cash Ratio 2.32

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -4.4
Shareholder Yield % -11.47
Name Current Vs Industry Vs History
ROA % -24.18
ROIC % -150.87
ROC (Joel Greenblatt) % -224.1
ROCE % -42.74

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -19.45
EV-to-EBITDA -22.11
EV-to-Forward-EBITDA -8.67
EV-to-Forward-Revenue 38.85
EV-to-FCF -9.86
Earnings Yield (Greenblatt) % -5.14
FCF Yield % -10.48

Financials (Next Earnings Date:2025-01-30 Est.)

SCNLF's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:SCNLF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Scancell Holdings PLC Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.02
Beta -1.17
Volatility % 46.38
14-Day RSI 1.03
14-Day ATR ($) 0.001194
20-Day SMA ($) 0.195525
12-1 Month Momentum % 29.22
52-Week Range ($) 0.1255 - 0.2335
Shares Outstanding (Mil) 929.6

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Scancell Holdings PLC Filings

Filing Date Document Date Form
No Filing Data

Scancell Holdings PLC Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Scancell Holdings PLC Frequently Asked Questions

What is Scancell Holdings PLC(SCNLF)'s stock price today?
The current price of SCNLF is $0.18. The 52 week high of SCNLF is $0.23 and 52 week low is $0.13.
When is next earnings date of Scancell Holdings PLC(SCNLF)?
The next earnings date of Scancell Holdings PLC(SCNLF) is 2025-01-30 Est..
Does Scancell Holdings PLC(SCNLF) pay dividends? If so, how much?
Scancell Holdings PLC(SCNLF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1